XOSPATA® (gilteritinib) | Official Patient Site XOSPATA Support Solutions can help provide you or your loved one with information about financial assistance programs What is the most important information I should know about XOSPATA? XOSPATA may cause serious side effects including Differentiation Syndrome
Xospata (Gilteritinib Tablets): Side Effects, Uses, Dosage . . . - RxList Our Xospata (gilteritinib) Tablets, for Oral Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication Gilteritinib is a tyrosine kinase inhibitor
Xospata (gilteritinib): Uses, Side Effects, Dosage Reviews Xospata (gilteritinib) treats adults with acute myeloid leukemia (AML) that has a specific FLT3 mutation This medication is approved for people who’ve tried other treatments before to treat their leukemia
XOSPATA® (gilteritinib) Official Site for Healthcare Professionals XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test WARNING: DIFFERENTIATION SYNDROME
MEDICATION GUIDE XOSPATA (Zoh spah tah) (gilteritinib) tablets What is . . . SPATA is a prescription medicine used to treat ad lts with acute myeloid leukemia (AML) who have a FMS-like tyrosine kinase 3 (FLT3) mutat on: • when the disease has come back, or • has not improv ent(s) Your healthcare provider will perform a test to make sure that
XOSPATA® (gilteritinib) Dosing Administration XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test WARNING: DIFFERENTIATION SYNDROME
Gilteritinib - Wikipedia Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug [6] Gilteritinib acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor [7] Gilteritinib was developed by Astellas Pharma